- Companies
- Emyria
Emyria Valuation Multiples
Emyria is valued at $17M as of November 2026, a 4.5x revenue multiple. In the last 12 months, Emyria revenue was $3M and Emyria EBITDA was ($4M).
Emyria Overview
About Emyria
Emyria Ltd operates a network of specialist medical clinics and uses purpose-built software and technology to gather clinical data from consenting patients. It operates in one segment of research and development.
Founded
2018
HQ
Employees
N/A
Website
Sectors
Financials (LTM)
EV
$13M
Valuation Multiples
Start free trialEmyria Financials
Emyria reported last 12-month revenue of $3M and negative EBITDA of ($4M).
In the same LTM period, Emyria generated ($4M) in gross profit, ($4M) in EBITDA losses, and had net loss of ($4M).
Revenue (LTM)
Emyria P&L
In the most recent fiscal year, Emyria reported revenue of $3M and EBITDA of ($4M).
Emyria is unprofitable as of last fiscal year, with gross margin of 19%, EBITDA margin of (146%), and net margin of (158%).
Financial data powered by Morningstar, Inc.
Emyria Stock Performance
Emyria has current market cap of $17M, and enterprise value of $13M.
Market Cap Evolution
Emyria's stock price is $0.02.
Emyria share price decreased by 22.1% in the last 30 days, and by 17.0% in the last year.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $13M | $17M | -0.2% | -22.1% | -33.8% | -17.0% | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEmyria Valuation Multiples
Emyria trades at 4.5x EV/Revenue multiple, and (3.4x) EV/EBITDA.
EV / Revenue (LTM)
Emyria Financial Valuation Multiples
As of November 22, 2026, Emyria has market cap of $17M and EV of $13M.
Emyria has a P/E ratio of (4.0x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Emyria Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Emyria Margins & Growth Rates
Emyria grew revenue by 154% and EBITDA by 28% in the last fiscal year.
In the most recent fiscal year, Emyria reported gross margin of 19%, EBITDA margin of (146%), and net margin of (158%).
Emyria Margins
Emyria Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Emyria Operational KPIs
Emyria's Rule of 40 is 48% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Emyria's Rule of X is 260% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Emyria Competitors
Emyria competitors include Maternus-Kliniken, Concord Medical Services, Eukedos, MedNation, Speed Medical SAE, Gesundheitswelt Chiemgau, Amwill Healthcare, Zicix, Clinica de Marly and Talis Biomedical.
Most Emyria public comparables operate across Hospitals & Clinics.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $130M | $4M | 1.9x | - | 55.6x | - | |||
| $69M | ($12M) | 15.3x | - | (86.6x) | - | |||
| $58M | $12M | 2.6x | - | 12.4x | - | |||
| $58M | $6M | 0.3x | - | 3.5x | - | |||
| - | - | - | - | - | - | |||
| $90M | $9M | 0.6x | - | 6.1x | - | |||
| $5M | $1M | 1.3x | - | 4.7x | - | |||
| $731K | ($699K) | 10.8x | - | (11.3x) | - | |||
This data is available for Pro users. Sign up to see all Emyria competitors and their valuation data. Start Free Trial | ||||||||
Emyria VC Funding History
Before going public, Emyria raised $4M in total equity funding, across 1 round.
Last private valuation of Emyria was $49M, after raising $4M in November 2021 from Tattarang.
Emyria Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Emyria
| When was Emyria founded? | Emyria was founded in 2018. |
| Where is Emyria headquartered? | Emyria is headquartered in Australia. |
| Is Emyria publicly listed? | Yes, Emyria is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Emyria? | Emyria trades under EMD ticker. |
| When did Emyria go public? | Emyria went public in 2020. |
| Who are competitors of Emyria? | Emyria main competitors include Maternus-Kliniken, Concord Medical Services, Eukedos, MedNation, Speed Medical SAE, Gesundheitswelt Chiemgau, Amwill Healthcare, Zicix, Clinica de Marly, Talis Biomedical. |
| What is the current market cap of Emyria? | Emyria's current market cap is $17M. |
| What is the current revenue of Emyria? | Emyria's last 12 months revenue is $3M. |
| What is the current revenue growth of Emyria? | Emyria revenue growth (NTM/LTM) is 213%. |
| What is the current EV/Revenue multiple of Emyria? | Current revenue multiple of Emyria is 4.5x. |
| Is Emyria profitable? | No, Emyria is not profitable. |
| What is the current EBITDA of Emyria? | Emyria has negative EBITDA and is not profitable. |
| What is Emyria's EBITDA margin? | Emyria's last 12 months EBITDA margin is (133%). |
| What is the current EV/EBITDA multiple of Emyria? | Current EBITDA multiple of Emyria is (3.4x). |
| What is the current FCF of Emyria? | Emyria's last 12 months FCF is ($4M). |
| What is Emyria's FCF margin? | Emyria's last 12 months FCF margin is (123%). |
| What is the current EV/FCF multiple of Emyria? | Current FCF multiple of Emyria is (3.7x). |
| How many companies Emyria has acquired to date? | Emyria hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Emyria has invested to date? | Emyria hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Emyria
Lists including Emyria
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




